Mirae Asset Global Investments Co., Ltd. Editas Medicine, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $28 Billion
- Q2 2025
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 3,234 shares of EDIT stock, worth $12,806. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,234
Previous 2,722
18.81%
Holding current value
$12,806
Previous $3,000
133.33%
% of portfolio
0.0%
Previous 0.0%
Shares
24 transactions
Others Institutions Holding EDIT
# of Institutions
218Shares Held
45.5MCall Options Held
476KPut Options Held
338K-
Black Rock Inc. New York, NY7.78MShares$30.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.16MShares$28.4 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.96MShares$7.78 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.88MShares$7.43 Million0.0% of portfolio
-
State Street Corp Boston, MA1.85MShares$7.31 Million0.0% of portfolio
About Editas Medicine, Inc.
- Ticker EDIT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,737,200
- Market Cap $272M
- Description
- Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...